A randomized, double-blind, placebo-controlled crossover trial using valaciclovir to suppress HSV [herpes simplex virus] and HIV shedding in HIV-1, HSV-2 coinfected persons
Phase of Trial: Phase IV
Latest Information Update: 09 Dec 2015
At a glance
- Drugs Valaciclovir (Primary)
- Indications Herpes simplex virus infections; HIV-1 infections
- Focus Therapeutic Use
- 20 Jun 2007 Status changed from in progress to completed.
- 15 Sep 2006 Status change
- 22 Nov 2005 New trial record.